Robert B Hawkins1, J Hunter Mehaffey1, Timothy L McMurry2, Jennifer Kirby3, Steven K Malin4, Bruce Schirmer1, Peter T Hallowell5. 1. Department of Surgery, University of Virginia, Charlottesville, Virginia. 2. Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia. 3. Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia, Charlottesville, VA. 4. Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia, Charlottesville, Virginia; Department of Kinesiology, University of Virginia, Charlottesville, Virginia. 5. Department of Surgery, University of Virginia, Charlottesville, Virginia. Electronic address: PTH2F@virginia.edu.
Abstract
BACKGROUND: Although Roux-en-Y gastric bypass (RYGB) induces short-term weight loss and co-morbidity amelioration, long-term data suggest that a subset of patients return to their preoperative body mass index (BMI). OBJECTIVES: To identify the clinical implications of 10-year weight loss failure after RYGB. SETTING: An academic teaching hospital. METHODS: Adults undergoing RYGB (1985-2004) were included in this study (n = 1087). Absolute weight loss failure was defined as ≤0% reduction in excess BMI 10 years after surgery. Univariate analyses compared co-morbidity rates and resolution by weight loss classification. Multivariable regression modeling analyzed preoperative predictors of 10-year percent reduction in excess BMI and weight loss failure. RESULTS: Complete follow-up was available for 617 (57%) patients with a 10-year median percent reduction in excess BMI of 57.1%; 10.2% of patients had weight loss failure. Prevalence of all co-morbidities decreased, even in patients with weight loss failure (all P<.05). Compared with patients with successful weight loss, patients with weight loss failure had similar rates of resolution of pre-existing co-morbidities, except for reduced resolution of apnea and cardiac co-morbidities (both P<.05). Risk factors for weight loss failure included lower BMI, nongovernmental insurance, longer travel time to hospital, and year of surgery. Nongovernmental insurance (odds ratio 2.03, P = .036) conferred the highest adjusted odds of weight loss failure. CONCLUSIONS: The vast majority of patients experience dramatic health improvement 10 years after RYGB, even though some patients fail to maintain their weight loss. Renewed focus should be placed on prevention and treatment of chronic disease, with further investigation of weight loss independent mechanisms of health improvement.
BACKGROUND: Although Roux-en-Y gastric bypass (RYGB) induces short-term weight loss and co-morbidity amelioration, long-term data suggest that a subset of patients return to their preoperative body mass index (BMI). OBJECTIVES: To identify the clinical implications of 10-year weight loss failure after RYGB. SETTING: An academic teaching hospital. METHODS: Adults undergoing RYGB (1985-2004) were included in this study (n = 1087). Absolute weight loss failure was defined as ≤0% reduction in excess BMI 10 years after surgery. Univariate analyses compared co-morbidity rates and resolution by weight loss classification. Multivariable regression modeling analyzed preoperative predictors of 10-year percent reduction in excess BMI and weight loss failure. RESULTS: Complete follow-up was available for 617 (57%) patients with a 10-year median percent reduction in excess BMI of 57.1%; 10.2% of patients had weight loss failure. Prevalence of all co-morbidities decreased, even in patients with weight loss failure (all P<.05). Compared with patients with successful weight loss, patients with weight loss failure had similar rates of resolution of pre-existing co-morbidities, except for reduced resolution of apnea and cardiac co-morbidities (both P<.05). Risk factors for weight loss failure included lower BMI, nongovernmental insurance, longer travel time to hospital, and year of surgery. Nongovernmental insurance (odds ratio 2.03, P = .036) conferred the highest adjusted odds of weight loss failure. CONCLUSIONS: The vast majority of patients experience dramatic health improvement 10 years after RYGB, even though some patients fail to maintain their weight loss. Renewed focus should be placed on prevention and treatment of chronic disease, with further investigation of weight loss independent mechanisms of health improvement.
Authors: J Hunter Mehaffey; Damien J LaPar; Kathleen C Clement; Florence E Turrentine; Michael S Miller; Peter T Hallowell; Bruce D Schirmer Journal: Ann Surg Date: 2016-07 Impact factor: 12.969
Authors: Matthew L Maciejewski; David E Arterburn; Lynn Van Scoyoc; Valerie A Smith; William S Yancy; Hollis J Weidenbacher; Edward H Livingston; Maren K Olsen Journal: JAMA Surg Date: 2016-11-01 Impact factor: 14.766
Authors: J Hunter Mehaffey; Florence E Turrentine; Michael S Miller; Bruce D Schirmer; Peter T Hallowell Journal: Surg Obes Relat Dis Date: 2015-12-01 Impact factor: 4.734
Authors: Lars Sjöström; Markku Peltonen; Peter Jacobson; Sofie Ahlin; Johanna Andersson-Assarsson; Åsa Anveden; Claude Bouchard; Björn Carlsson; Kristjan Karason; Hans Lönroth; Ingmar Näslund; Elisabeth Sjöström; Magdalena Taube; Hans Wedel; Per-Arne Svensson; Kajsa Sjöholm; Lena M S Carlsson Journal: JAMA Date: 2014-06-11 Impact factor: 56.272
Authors: Daniel McKenna; Don Selzer; Michael Burchett; Jennifer Choi; Samer G Mattar Journal: Surg Obes Relat Dis Date: 2013-12-18 Impact factor: 4.734
Authors: Wanda M Admiraal; Funda Celik; Victor E Gerdes; Ramsey M Dallal; Joost B Hoekstra; Frits Holleman Journal: Diabetes Care Date: 2012-09 Impact factor: 19.112
Authors: Rena C Moon; Andre F Teixeira; Manoel Galvao Neto; Natan Zundel; Bruno Queiroz Sander; Flavio Mitidieri Ramos; Felipe Matz; Giorgio A Baretta; Luiz Gustavo de Quadros; Eduardo Grecco; Thiago Souza; Sergio A Barrichello; Admar Concon Filho; Eduardo Nobuyuki Usuy; Artagnan Menezes Barbosa de Amorim; Muhammad A Jawad Journal: Obes Surg Date: 2018-09 Impact factor: 4.129
Authors: Nawfal W Istfan; Wendy A Anderson; Donald T Hess; Liqun Yu; Brian Carmine; Caroline M Apovian Journal: Obesity (Silver Spring) Date: 2020-06 Impact factor: 5.002
Authors: Kamal K Mahawar; Abdelrahman Nimeri; Marco Adamo; Cynthia-Michelle Borg; Rishi Singhal; Omar Khan; Peter K Small Journal: Obes Surg Date: 2018-09 Impact factor: 4.129
Authors: Dylan D Thomas; Wendy A Anderson; Caroline M Apovian; Donald T Hess; Liqun Yu; Amanda Velazquez; Brian Carmine; Nawfal W Istfan Journal: Obesity (Silver Spring) Date: 2018-11-13 Impact factor: 5.002
Authors: Fernando Rodríguez; Antonio Herrera; Elisa M Sepúlveda; Lizbeth Guilbert; Louis A Hernández; Luis F Peñuñuri; Fátima M Rodríguez; Carlos Zerrweck Journal: Langenbecks Arch Surg Date: 2022-01-11 Impact factor: 3.445